Patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients.

by Linda Brom, H Roeline W Pasman, Guy A M Widdershoven, Maurice J D L van der Vorst, Jaap C Reijneveld, Tjeerd J Postma, Bregje D Onwuteaka-Philipsen
Published 2014-01-01

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin

by Maurice J. D. L. van der Vorst, Elisabeth C. W. Neefjes, Elisa C. Toffoli, Jolanda E. W. Oosterling-Jansen, Marije R. Vergeer, C. René Leemans, Menno P. Kooistra, Jens Voortman, Henk M. W. Verheul
Published 2019-11-01

Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

by Elisabeth C. W. Neefjes, Maurice J. D. L. van der Vorst, Manon S. A. Boddaert, Bea A. T. T. Verdegaal, Aart Beeker, Saskia C. C. Teunissen, Aartjan T. F. Beekman, Wouter W. A. Zuurmond, Johannes Berkhof, Henk M. W. Verheul
Published 2019-02-01

Optimal treatment of opioid induced constipation in daily clinical practice – an observational study

by Elisabeth C. W. Neefjes, Hanneke van der Wijngaart, Maurice J. D. L. van der Vorst, Diederik ten Oever, Hans J. van der Vliet, Aart Beeker, Christiaan A. Rhodius, Hendrik P. van den Berg, Johannes Berkhof, Henk M. W. Verheul
Published 2019-03-01